Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-18-001673
Filing Date
2018-03-08
Accepted
2018-03-07 20:09:24
Documents
5
Period of Report
2018-04-17
Effectiveness Date
2018-03-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A s109241_def14a.htm DEF 14A 441494
2 GRAPHIC img001_v1.jpg GRAPHIC 659
3 GRAPHIC img002_v1.jpg GRAPHIC 2586
4 GRAPHIC img003_v1.jpg GRAPHIC 1907
5 GRAPHIC img004_v1.jpg GRAPHIC 2641
  Complete submission text file 0001615774-18-001673.txt   453935
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37606 | Film No.: 18674797
SIC: 8731 Services-Commercial Physical & Biological Research